Literature DB >> 25920354

Five critical elements to ensure the precision medicine.

Chengshui Chen1, Mingyan He, Yichun Zhu, Lin Shi, Xiangdong Wang.   

Abstract

The precision medicine as a new emerging area and therapeutic strategy has occurred and was practiced in the individual and brought unexpected successes, and gained high attentions from professional and social aspects as a new path to improve the treatment and prognosis of patients. There will be a number of new components to appear or be discovered, of which clinical bioinformatics integrates clinical phenotypes and informatics with bioinformatics, computational science, mathematics, and systems biology. In addition to those tools, precision medicine calls more accurate and repeatable methodologies for the identification and validation of gene discovery. Precision medicine will bring more new therapeutic strategies, drug discovery and development, and gene-oriented treatment. There is an urgent need to identify and validate disease-specific, mechanism-based, or epigenetics-dependent biomarkers to monitor precision medicine, and develop "precision" regulations to guard the application of precision medicine.

Entities:  

Mesh:

Year:  2015        PMID: 25920354     DOI: 10.1007/s10555-015-9555-3

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  16 in total

Review 1.  Tumor Heterogeneity, Single-Cell Sequencing, and Drug Resistance.

Authors:  Felix Schmidt; Thomas Efferth
Journal:  Pharmaceuticals (Basel)       Date:  2016-06-16

2.  Cancer Moonshot 2020: a new march of clinical and translational medicine.

Authors:  Xiangdong Wang
Journal:  Clin Transl Med       Date:  2016-03-10

3.  Labeling for Big Data in radiation oncology: The Radiation Oncology Structures ontology.

Authors:  Jean-Emmanuel Bibault; Eric Zapletal; Bastien Rance; Philippe Giraud; Anita Burgun
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

Review 4.  Phenotypic Plasticity, Bet-Hedging, and Androgen Independence in Prostate Cancer: Role of Non-Genetic Heterogeneity.

Authors:  Mohit Kumar Jolly; Prakash Kulkarni; Keith Weninger; John Orban; Herbert Levine
Journal:  Front Oncol       Date:  2018-03-06       Impact factor: 6.244

Review 5.  Current status and perspectives of patient-derived xenograft models in cancer research.

Authors:  Yunxin Lai; Xinru Wei; Shouheng Lin; Le Qin; Lin Cheng; Peng Li
Journal:  J Hematol Oncol       Date:  2017-05-12       Impact factor: 17.388

Review 6.  Advanced EUS Guided Tissue Acquisition Methods for Pancreatic Cancer.

Authors:  Pujan Kandel; Michael B Wallace
Journal:  Cancers (Basel)       Date:  2018-02-17       Impact factor: 6.639

7.  The development of precision medicine in clinical practice.

Authors:  Mingyan He; Jinglin Xia; Mohamed Shehab; Xiangdong Wang
Journal:  Clin Transl Med       Date:  2015-08-25

Review 8.  Potentials of single-cell biology in identification and validation of disease biomarkers.

Authors:  Furong Niu; Diane C Wang; Jiapei Lu; Wei Wu; Xiangdong Wang
Journal:  J Cell Mol Med       Date:  2016-04-26       Impact factor: 5.310

9.  Gene mutation-based and specific therapies in precision medicine.

Authors:  Xiangdong Wang
Journal:  J Cell Mol Med       Date:  2016-04       Impact factor: 5.310

10.  Paralog-divergent Features May Help Reduce Off-target Effects of Drugs: Hints from Glucagon Subfamily Analysis.

Authors:  Zhining Sa; Jingqi Zhou; Yangyun Zou; Zhixi Su; Xun Gu
Journal:  Genomics Proteomics Bioinformatics       Date:  2017-06-20       Impact factor: 6.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.